MedTrace Logo

Wound Additives in Primary Total Joint Athroplasty

NCT03158623 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2017-05-18

No results posted yet for this study

Summary

3 cohorts of total joint patient of 30 members each were randomized to receive PRP or Activated Collegen or no additive were studied for status of the wound at 6 weeks and recorded all complications, infections and reoperations. The three groups were than compared for statistical analysis

Conditions

  • Arthroplasty, Replacement

Interventions

BIOLOGICAL

Platelet Rich Plasma

BIOLOGICAL

Cellerate

Sponsors & Collaborators

  • Salt Lake Orthopedic Clinic

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-04-01
Primary Completion
2016-12-06
Completion
2016-12-20

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03158623 on ClinicalTrials.gov